Carol Aristimuño - Concepedia

Author

Carol Aristimuño

Hospital General Universitario Gregorio Marañón

Also Known As

C. Aristimuño, Carol Aristimuño

Publications

463

Citations

H-Index

Concepts

All Affiliations

Hospital General Universitario Gregorio Marañón Hospital Clínico San Carlos Institut Curie Inserm

About

Carol Aristimuño is an author at Hospital General Universitario Gregorio Marañón specializing in immunology, medicine, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	366
2	Immunology	7	7	366
3	Cell Biology	3	3	216
4	Public Health	1	1	76
5	Allergy	1	1	21

Carol Aristimuño

Publications

454

Citations

H-Index

Page 1

	Year	Citations
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing−remitting multiple sclerosis Clara de Andrés, Carol Aristimuño, Virginia de las Heras, Journal of Neuroimmunology Autoimmune DiseaseImmune DysregulationMedicineT-regulatory CellImmune Regulation	2006	128
Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity Silvia Sánchez‐Ramón, Joaquín Navarroa, Carol Aristimuño, Immunology Letters Maternal ImmunizationRegulatory T-lymphocytesAutoimmune DiseaseMedicineT-regulatory Cell	2004	76
Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: Differential short-term changes on corticosteroids therapy J. Navarro, Carol Aristimuño, Silvia Sánchez‐Ramón, Journal of Neuroimmunology Multiple Sclerosis RelapseAutoimmune DiseaseMedicineT-regulatory CellImmune Regulation	2006	57
Estradiol-dependent perforin expression by human regulatory T-cells L. Valor, Roseta Teijeiro, Carol Aristimuño, European Journal of Clinical Investigation	2010	48
Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis Carol Aristimuño, Roseta Teijeiro, Lara Valor, Clinical and Experimental Medicine Autoimmune DiseaseMedicineHormonal ReceptorT-regulatory CellImmunology	2012	47
IFNβ-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: A longitudinal 1-year study Carol Aristimuño, Clara de Andrés, Manuel Bartolomé, Clinical Immunology Autoimmune DiseaseImmune Cell DevelopmentMedicineImmunologyImmune Regulation	2009	25
A Complete In Vitro Toxicological Assessment of the Biological Effects of Cerium Oxide Nanoparticles: From Acute Toxicity to Multi-Dose Subchronic Cytotoxicity Study Adrián García-Salvador, Alberto Katsumiti, Elena Rojas, Nanomaterials	2021	23
Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after iv methyl-prednisolone for multiple sclerosis relapse Carol Aristimuño, J. Navarro, Carolina Deandres, Journal of Neuroimmunology Multiple Sclerosis RelapseAllergyAutoimmune DiseaseLymphocyte DevelopmentMedicine	2008	21
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences Marta Tejera‐Alhambra, Bárbara Alonso, Roseta Teijeiro, International Journal of Molecular Sciences	2012	17
Clinical response to interferon-β-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Clara de Andrés, Carol Aristimuño, Manuel Bartolomé, Journal of Neuroimmunology InflammationCytokineHematological MalignancyLow BaselineImmune Cell Development	2009	12

Page 1